Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
Atherosclerosis happens though a complicated process of cholesterol plaque formation that involves what |
Damaged endothelium Cholesterol invasion Plaque formation |
|
What is hyperlipidemia |
Classified at familial causes by specific genetic abnormalities or acquired when resulting from another underlying disorder that leads to alterations in plasma lipid and lipoprotein metabolism |
|
What are the drugs therapy for hyperlipidemia |
Statins, bile acid sequestrants, niacin, fibric acid derivatives, ezetimibe and the inhibition of dietary cholesterol |
|
Increase in serum cholesterol levels is in positive correlation with what |
Disease development |
|
What do statins inhibit |
An early and rate limiting step in cholesterol biosynthesis Hepatic cholesterol sythesis results in increased expression of the LDL receptor gene It also reduces the degradation of LDL receptors |
|
By satins inhibiting hepatic cholesterol synthesis results in increased expression of the LDL receptor gene, what does decreased free cholesterol cause |
Membrane bound SREBPs to be cleaved and translocated to the nucleus to bind the sterol responsive element of the LDL receptor gene, it enhances transcription and increases synthesis of ldl receptors |
|
Form acetyl coA to CHOLESTEROL and whats the rate limiting step1) |
Acetyl coA to HMG CoA to mevalonate(by HMG-CoA reductase) to farnesyl pyrophosphate to squalene to cholesterol Rate limiting steonis HMG COA REDUCTASE |
|
2) whats the biproduct if farnesyl pyrophosphate |
Farnesylates proteins |
|
3) whats the biproduct of squalene |
Dolichol Geranylgeranyl pyrophosphate which goes into geranylgeranylated proteins or ubiquinones |
|
What are rho and rac |
Monomeric proteins |
|
What is rho |
Blocks eNOS (good in cardioprotection) |
|
What is rac |
Produces superoxide nadpH |
|
Where to rho and rac come from |
Geranylgranyl PP |
|
What are competative inhibitors of HMG-CoA reductase |
Statins |
|
what are statins documented in reducing |
Fatal and non fatal CHD events, strokes and total mortality |
|
Why do we want a increased expression of LDL receptor gene |
Greater number of LDL receptors on the surface if hepatocytes results in increased removal of LDL from the blood and therefore lowering LDL-C levels |
|
Whats statins effects on triglycerides |
Decreases triglycerides in hypertriglyceridemic Increase HDL-C Decrease LDL-C |
|
Statins effect on non-lipid lowering effects |
Endothelial function (enhances production of nitric oxide Anti inflammatory Reduce venous thromboembolic events |
|
Adverse effects of statins |
Hepatotoxicity Myopathy |
|
What are the statin clinical trials and whats the end points |
Statin vs placebo,Statin vs statin Disease outcome and surrogate marker( not directly related to statin itself i.e production of blood pressure) cholesterol would be the first marker but surrogate is something else |
|
What are the benefits and risks of statins? Therapeutic effects and adverse effects |
Therapeutic-cardiovascular protection Adverse- muscle, liver, drug interactions |